Business

Macy’s, the well-established department store chain with a history spanning 165 years, is grappling with declining sales and a struggling stock amid a thriving market. In an effort to keep up with newer competitors such as direct-to-consumer brands, online giants like Amazon and Shein, and big-box players like Target, Macy’s is placing its bets on
UnitedHealth Group, the largest healthcare company in the United States, experienced a surge in stock prices after reporting impressive second-quarter revenue and adjusted earnings that surpassed Wall Street’s predictions. Despite concerns over rising medical costs and an increase in demand for non-urgent surgeries and outpatient services, the company managed to ease investor worries. UnitedHealth Group’s
In a strategic move to accelerate the development of artificial intelligence (AI) models for drug discovery, chipmaker Nvidia has announced its plan to invest $50 million in Recursion Pharmaceuticals. Following this announcement, Recursion’s stock experienced a significant surge of 80%, while Nvidia’s shares also rose by more than 2%. This investment aims to leverage Nvidia’s
Only approximately one-third of patients who are prescribed weight loss drugs, such as Wegovy, a popular injection developed by Novo Nordisk, continue taking the medication after a year. Surprisingly, the total healthcare costs for this group actually increased, according to an analysis conducted by Prime Therapeutics, a leading pharmacy benefit manager in the United States.
Several major US banks, including JPMorgan Chase, Wells Fargo, and Morgan Stanley, have announced their intention to raise their quarterly dividends after successfully completing the Federal Reserve’s annual stress test. JPMorgan plans to increase its payout from $1 to $1.05 per share starting in the third quarter, pending board approval. According to JPMorgan CEO Jamie